Document Detail


Assessment of osteoporosis in psoriasis with and without arthritis: correlation with disease severity.
MedLine Citation:
PMID:  21182499     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
BACKGROUND: The most frequent extracutaneous association with psoriasis is arthritis. Because proinflammatory cytokines are increased in psoriasis, patients with this disease may be more prone to osteoporosis than the healthy individuals.
METHODS: We evaluated 50 patients with psoriasis, with or without psoriatic arthritis (PsA), for the presence and degree of osteoporosis by performing dual energy x-ray absorptiometry (DEXA) and obtaining serum osteoprotegrin (OPG) levels. In addition, we correlated these results with the extent of skin and joint disease. Psoriasis area and severity index (PASI) was determined in all 50 patients with psoriasis, and total joint score (TJS) was recorded in the 16 patients who also had PsA. Results of DEXA and serum OPG were also obtained for 20 healthy individuals who served as controls.
RESULTS: Osteoprotegrin level was significantly increased in psoriasis patients (with or without PsA) vs. controls. However, DEXA revealed that PsA patients had a higher degree of osteoporosis in the femur neck and wrist. In PsA patients, TJS correlated positively with both disease duration and PASI but correlated negatively with Z score of the femur.
CONCLUSION: Psoriasis patients with or without arthritis may suffer from osteoporosis as evidenced by significantly increased serum OPG. Prolonged and extensive cutaneous disease is an important risk factor for the development and severity of PsA. Patients with a greater number of affected joints are at higher risk of osteoporosis.
Authors:
Enas A S Attia; Ayman Khafagy; Sameh Abdel-Raheem; Sahar Fathi; Abeer A Saad
Related Documents :
17960639 - A comprehensive review of rfviia use in a tertiary care pediatric center.
2743849 - Prothrombotic abnormalities in inflammatory bowel disease.
10919409 - Correlation between factor viii genotype and inhibitor development in hemophilia a.
11460009 - Maximal endothelial tissue plasminogen activator release is not impaired in patients wi...
18345709 - Recombinant factor viia (eptacog alfa): a review of its use in congenital hemophilia wi...
21445609 - Pulmonary vascular disease in gaucher disease: clinical spectrum, determinants of pheno...
19381759 - Ultrasonography as a predictor of overt bleeding after renal biopsy.
21952179 - Periventricular white matter injury by primary intraventricular hemorrhage: a diffusion...
301449 - Immunological studies of patients with asbestosis. ii, studies of circulating lymphoid ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of dermatology     Volume:  50     ISSN:  1365-4632     ISO Abbreviation:  Int. J. Dermatol.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-12-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0243704     Medline TA:  Int J Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  30-5     Citation Subset:  IM    
Copyright Information:
© 2011 The International Society of Dermatology.
Affiliation:
Departments of Dermatology, Venereology, and Andrology, Faculty of Medicine, Ain Shams University, Cairo, Egypt. annosah74@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immunohistochemical expression of cyclooxygenage-2 in melanocytic skin lesions.
Next Document:  Prurigo pigmentosa: a clinicopathological study and analysis of associated factors.